NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/18/2025
Back to search
Official data from USPTO
COSETTE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
COSETTE PHARMACEUTICALS
ST13
US500000098530903Class
5, 42
Filing
98530903
Registration
7729290
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
03/19/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
05/02/2024
Registration date
03/18/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2025
Last transaction
03/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/30/2019
First use in commerce
09/02/2022
Drawing code
4
Owner type
03
Owner location
Bridgewater, NJ
Examiner
TWAY, TATIANA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Cosette Pharmaceuticals, Inc.
Representatives
Mark A. Mazza Eckert Seamans Cherin & Mellott, LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations, namely, analgesics, antifungals, anti-inflammatories, antiemetics, antibiotics, contraceptives, hypnotics, and laxatives; Pharmaceutical preparations and substances for the treatment of infertility, cardiovascular, cardiopulmonary, sexual dysfunction, gastrointestinal, hormonal, dermatological, psychiatric, neurological, viral, metabolic, endocrine, musculoskeletal, and immune system related diseases and disorders
Class 42
Development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2025
PUBO
PUBLISHED FOR OPPOSITION
01/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/25/2024
GNRT
NON-FINAL ACTION E-MAILED
11/25/2024
CNRT
NON-FINAL ACTION WRITTEN
11/25/2024
DOCK
ASSIGNED TO EXAMINER
11/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/16/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/24/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/24/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/24/2024
NWAP
NEW APPLICATION ENTERED
05/02/2024
Continuous trademark protection
Get notified about every new filing that threatens COSETTE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.